2022年5月1日简报:上海连续第2天社会面清零;台湾新增15033例本土确诊病例;北京9天295例新冠肺炎病毒感染者;丹麦将终止大规模疫苗接种计划

2022-05-01 MedSci整理 MedSci整理

截至北京时间2022年5月1日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过5亿1322万例,新增419,046例,达到513,229,38

截至北京时间2022年5月1日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过5亿1322万例,新增419,046例,达到513,229,380例。累计死亡病例626.0万例,达到6,260,331例。新增死亡为1,264例。康复为467,096,843例,重症和危重症病人达到41,131例;全球新冠确诊病例超过100万例的国家和地区达59个,126个国家和地区病例超10万例。昨日报道:2022年4月30日简报:上海新增本土1249+8932例,均在隔离管控中发现;北京昨日新增本土新冠感染者48+6例;中国台湾新增11974例;全球疫情略有反弹

上海昨日新增本土788+7084,第二天社会面清零

2022年4月30日0—24时,新增本土新冠肺炎确诊病例788和无症状感染者7084例,其中683例确诊病例为既往无症状感染者转归,105例确诊病例和7084例无症状感染者在隔离管控中发现。新增境外输入性新冠肺炎确诊病例1例和无症状感染者2例,均在闭环管控中发现。

北京9天295例新冠肺炎病毒感染者

4月30日下午召开的北京市新冠疫情防控第320场新闻发布会上获悉,4月22日以来,北京市累计报告295例新冠肺炎病毒感染者,涉及13个区,其中朝阳区123例、房山区72例、通州区31例、丰台区22例、顺义区21例、昌平区8例、海淀区6例、大兴区4例、西城区2例、石景山区2例、延庆区2例、东城区1例、门头沟区1例。

香港新增363宗新冠病毒阳性病例

特区政府卫生署卫生防护中心30日举行疫情简报会公布,截至当日零时,香港新增363宗新冠病毒阳性病例。

台湾新增15033例本土确诊病例 新增3例死亡病例

台湾地区流行疫情指挥中心30日公布,新增15149例新冠肺炎确诊病例,包括15033例本土病例和116例境外输入病例;另确诊病例中新增3例死亡病例。

指挥中心负责人表示,目前疫情尚未抵达巅峰,未来确诊数量还是会持续增加。

指挥中心说明,当日新增的15033例本土病例年龄介于未满5岁至90多岁,发病日介于4月18日至4月29日,其中8108例为无症状感染。个案分布以新北市5797例、台北市3099例为多。新增的116例境外输入病例年龄介于10多岁至70多岁。

指挥中心指出,今日新增3例本土病例死亡个案为1名男性、2名女性,年龄介于60多岁至80多岁,皆属重度感染个案且具有慢性病史,确诊日介于4月18日至4月25日,死亡日期介于4月23日至4月25日。

丹麦称“疫情受控”,将成为全球首个暂停大规模接种新冠疫苗的国家

丹麦政府27日宣布,将终止大规模疫苗接种计划,成为全球第一个暂停接种新冠疫苗计划的国家。丹麦政府表示,暂停接种是因为当地疫情已受控,但不排除今年秋季恢复接种的可能性。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2027154, encodeId=ff93202e15461, content=<a href='/topic/show?id=b0bf5808689' target=_blank style='color:#2F92EE;'>#新冠肺炎病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58086, encryptionId=b0bf5808689, topicName=新冠肺炎病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c64275, createdName=piaojinhua, createdTime=Tue May 31 01:22:45 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043486, encodeId=d420204348625, content=<a href='/topic/show?id=13304400293' target=_blank style='color:#2F92EE;'>#大规模#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44002, encryptionId=13304400293, topicName=大规模)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Sun May 29 09:22:45 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258164, encodeId=0e0612581640b, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Mon May 02 23:22:45 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617088, encodeId=9228161e0881c, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Mon May 02 23:22:45 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216025, encodeId=1efa1216025e4, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Sun May 01 11:34:06 CST 2022, time=2022-05-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2027154, encodeId=ff93202e15461, content=<a href='/topic/show?id=b0bf5808689' target=_blank style='color:#2F92EE;'>#新冠肺炎病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58086, encryptionId=b0bf5808689, topicName=新冠肺炎病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c64275, createdName=piaojinhua, createdTime=Tue May 31 01:22:45 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043486, encodeId=d420204348625, content=<a href='/topic/show?id=13304400293' target=_blank style='color:#2F92EE;'>#大规模#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44002, encryptionId=13304400293, topicName=大规模)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Sun May 29 09:22:45 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258164, encodeId=0e0612581640b, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Mon May 02 23:22:45 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617088, encodeId=9228161e0881c, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Mon May 02 23:22:45 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216025, encodeId=1efa1216025e4, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Sun May 01 11:34:06 CST 2022, time=2022-05-01, status=1, ipAttribution=)]
    2022-05-29 ylz8403
  3. [GetPortalCommentsPageByObjectIdResponse(id=2027154, encodeId=ff93202e15461, content=<a href='/topic/show?id=b0bf5808689' target=_blank style='color:#2F92EE;'>#新冠肺炎病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58086, encryptionId=b0bf5808689, topicName=新冠肺炎病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c64275, createdName=piaojinhua, createdTime=Tue May 31 01:22:45 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043486, encodeId=d420204348625, content=<a href='/topic/show?id=13304400293' target=_blank style='color:#2F92EE;'>#大规模#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44002, encryptionId=13304400293, topicName=大规模)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Sun May 29 09:22:45 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258164, encodeId=0e0612581640b, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Mon May 02 23:22:45 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617088, encodeId=9228161e0881c, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Mon May 02 23:22:45 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216025, encodeId=1efa1216025e4, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Sun May 01 11:34:06 CST 2022, time=2022-05-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2027154, encodeId=ff93202e15461, content=<a href='/topic/show?id=b0bf5808689' target=_blank style='color:#2F92EE;'>#新冠肺炎病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58086, encryptionId=b0bf5808689, topicName=新冠肺炎病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c64275, createdName=piaojinhua, createdTime=Tue May 31 01:22:45 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043486, encodeId=d420204348625, content=<a href='/topic/show?id=13304400293' target=_blank style='color:#2F92EE;'>#大规模#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44002, encryptionId=13304400293, topicName=大规模)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Sun May 29 09:22:45 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258164, encodeId=0e0612581640b, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Mon May 02 23:22:45 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617088, encodeId=9228161e0881c, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Mon May 02 23:22:45 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216025, encodeId=1efa1216025e4, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Sun May 01 11:34:06 CST 2022, time=2022-05-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2027154, encodeId=ff93202e15461, content=<a href='/topic/show?id=b0bf5808689' target=_blank style='color:#2F92EE;'>#新冠肺炎病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58086, encryptionId=b0bf5808689, topicName=新冠肺炎病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c64275, createdName=piaojinhua, createdTime=Tue May 31 01:22:45 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043486, encodeId=d420204348625, content=<a href='/topic/show?id=13304400293' target=_blank style='color:#2F92EE;'>#大规模#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44002, encryptionId=13304400293, topicName=大规模)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Sun May 29 09:22:45 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258164, encodeId=0e0612581640b, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Mon May 02 23:22:45 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617088, encodeId=9228161e0881c, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Mon May 02 23:22:45 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216025, encodeId=1efa1216025e4, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Sun May 01 11:34:06 CST 2022, time=2022-05-01, status=1, ipAttribution=)]
    2022-05-01 xulv123

    认真学习~~

    0

相关资讯

中国台湾省新增11974例本土新冠肺炎病例,死亡2例,符合梅斯医学预测结果(2022.04.29)

中国台湾流行疫情指挥中心今日(29日)公布,台湾新增12313例新冠确诊病例,分别为11974例本土病例及339例境外输入病例;确诊病例中新增2例死亡。

上海昨日新增本土确诊病例1249例、无症状感染者8932例,均在闭环管控中发现(2022.04.30)

“健康上海12320”微信公众号消息,2022年4月29日0—24时,新增本土新冠肺炎确诊病例1249和无症状感染者8932例,其中985例确诊病例为既往无症状感染

2022年4月30日简报:上海新增本土1249+8932例,均在隔离管控中发现;北京昨日新增本土新冠感染者48+6例;中国台湾新增11974例;全球疫情略有反弹

截至北京时间2022年4月30日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过5亿1273万例,新增556,664例,达到512,723,5

封控管理期间,哪些药物不能自行停药?

疫情期间,每周周日全天,刘康永主任在康沈路1478号,周浦医院康桥门诊部出诊

昨日新增本土1410+9293:全国疫情最新消息(2022.4.30)

全国新增死亡病例47例,均为上海本土病例;现有确诊病例26567例(其中重症病例458例)。

国家卫健委:要求各地设立“黄码医院”

进一步强化医疗机构内的疫情监测预警,发现确诊病例立即启动应急预案。